Ono Pharmaceutical Co., Ltd. (OPHLY)
5.564
+0.04
(+0.81%)
USD |
OTCM |
Feb 20, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 7.843B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 66.10% |
| Valuation | |
| PE Ratio | 18.74 |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 1.464 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.1482 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 69.70% |
Profile
| Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan. |
| URL | https://www.ono-pharma.com/ja |
| Investor Relations URL | https://www.ono-pharma.com/ir/library |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 07, 2026 (est.) |
| Last Earnings Release | Feb. 02, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 27, 2018 |
Profile
| Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan. |
| URL | https://www.ono-pharma.com/ja |
| Investor Relations URL | https://www.ono-pharma.com/ir/library |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 07, 2026 (est.) |
| Last Earnings Release | Feb. 02, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 27, 2018 |